期刊文献+

纤维蛋白沉积与静脉性溃疡形成的研究 被引量:3

Fibrin Deposition and Venous Ulceration
暂未订购
导出
摘要 以26例下肢静脉瓣膜关闭功能不全患者和15例正常者为对象,通过局部皮肤病理和超微结构观察,下肢静脉血tPA、PAI:检测发现1.静脉性溃疡及皮肤色素沉着区皮下毛细血管周围纤维蛋白沉积伴成纤维细胞钙盐沉着,坏死;2.患者皮肤营养障碍越严重,tPA越低,PAI越高,即纤溶活性越弱。结果表明:下肢静脉功能不全患者毛细血管周围纤维蛋白沉积形成的弥散屏障是静脉性溃疡形成的主要因素;血液纤溶活性降低造成的清除纤维蛋白能力减退加重了该病理过程。两者导致皮肤营养障碍性改变,直至溃疡形成。 Twenty six patients with venous insufficiency and 15 normal controls were studied by examining the histopatthological and ultrastructural changes of the overlying local skin and measuring the venous blood tPA and PAl. The results demonstrated that: (1) Biopies from the ulcerative and liposclerotic areas showed pericapillary fibrin deposition accompanied by calcium deposition in and necrosis of the fibroblasts. (2) The more marked the skin changs in patients with venous insufficiency, the weaker the fibrinolytic activity. It was concluded that: Extravascular deposition of fibrin blocking the diffusion and exchange of oxygen between the blood and tissue was the most important factor in the development of venous ulceration. The decrease of fibrinolytic activity incurred the decrease of removing the pericapillary fibrin deposition, and in combination with extravascular fibrin caused the venous ulceration.
出处 《上海第二医科大学学报》 CSCD 1992年第4期277-280,共4页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 静脉功能不全 静脉性溃疡 纤维蛋白 venous insufficiency venous ulceration fibrin tPA PAI
  • 相关文献

同被引文献21

  • 1无,蒋俊豪(整理),王玉琦(整理).共识报告——慢性静脉病变CEAP分级法的修订[J].中华外科杂志,2006,44(1):59-61. 被引量:96
  • 2谷涌泉,张建,齐立行,郭连瑞,张淑文,苏立,李建新,徐娟,俞恒锡,李学锋,崔世军,罗涛,吴英锋,齐一侠,汪忠镐.骨髓动员刺激后自体骨髓源单个核细胞移植治疗下肢缺血的初步临床研究[J].中国修复重建外科杂志,2006,20(10):1017-1020. 被引量:51
  • 3Chetta A, Zanini A, Foresi A, et al. Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy, 2005, 35(11): 1437-1442.
  • 4Lawall H, Bramlage P, Amann B. Treatment of peripheral arterial disease using stem and progenitor cell therapy. J Vasc Surg, 2010, 53(2): 445-453.
  • 5Prochazka V, Gumulec J, Jaluvka F, et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant, 2010, 19(11): 1413-1424.
  • 6Henning RJ. Stem cells in cardiac repair. Future Cardiol, 2011, 7(1): 99-117.
  • 7Hoffmann J, Glassford AJ, Doyle TC, et al. Angiogenic effects despite limited cell survival of bone marrow-derived mesenchymal stem cells under ischemia. Thorac Cardiovasc Surg, 2010, 58(3): 136-142.
  • 8Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res, 2010, 107(7): 913-922.
  • 9Lu D, Chen B, Liang Z, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial. Diabetes Res Clin Pract, 2011. [Epub ahead of print].
  • 10Wu SC, Marston W, Armstrong DG. Wound care: the role of advanced wound healing technologies. J Vasc Surg, 2010, 52(3 Suppl): 59S-66S.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部